Krystal Biotech Inc. (KRYS)
undefined
undefined%
At close: undefined
155.81
0.12%
After-hours Jan 06, 2025, 04:00 PM EST

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income 10.93M -139.97M -69.57M -32.17M -19.09M -10.89M -7.92M -1.15M
Depreciation & Amortization 5.01M 4.05M 2.77M 1.85M 748.00K 141.00K 23.00K 2.00K
Stock-Based Compensation 39.93M 33.23M 15.32M 3.27M 1.24M 792.00K 246.00K 33.00K
Other Working Capital 8.73M 4.07M 1.34M 145.00K -1.48M 399.00K 365.00K -245.00K
Other Non-Cash Items -106.79M -690.00K 1.49M 33.00K 67.00K 962.00K 3.26M 7.00K
Deferred Income Tax n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital -37.88M 2.81M 2.05M 928.00K -1.68M 511.00K 498.00K -203.00K
Operating Cash Flow -88.80M -100.57M -47.94M -26.08M -18.71M -9.45M -3.89M -1.31M
Capital Expenditures -11.80M -52.98M -68.34M -14.84M -6.40M -2.23M -210.00K -15.00K
Acquisitions n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments -508.78M -318.78M -190.46M -3.21M -9.07M -8.09M n/a n/a
Sales Maturities Of Investments 503.21M 257.68M 32.03M 6.87M 10.50M n/a n/a n/a
Other Investing Acitivies 100.00M n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow 82.64M -114.08M -226.77M -11.18M -4.97M -10.32M -210.00K -15.00K
Debt Repayment n/a n/a n/a n/a n/a n/a 2.30M 1.84M
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -749.00K -649.00K -7.96M n/a n/a n/a 7.00M 1.31M
Financial Cash Flow 202.75M 35.35M 347.69M 118.02M 107.53M 73.85M 51.77M 3.25M
Net Cash Flow 196.43M -179.35M 72.98M 80.75M 83.84M 54.08M 47.67M 1.92M
Free Cash Flow -100.60M -153.55M -116.27M -40.93M -25.11M -11.68M -4.10M -1.33M